4//SEC Filing
Foley Mark J 4
Accession 0000950170-25-014825
CIK 0001479290other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:53 PM ET
Size
5.9 KB
Accession
0000950170-25-014825
Insider Transaction Report
Form 4
Foley Mark J
DirectorCEO
Transactions
- Award
Common Stock
2025-02-03+27,933→ 1,024,868 total
Holdings
- 110,913(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Represents the vesting of performance-based restricted stock units (PSUs) granted on January 31, 2023, which vest over a three-year period based on the achievement of revenue goals. On February 3, 2025, the Issuer's Compensation Committee certified a portion of the PSUs eligible to vest based on (i) the achievement of a revenue goal, measured beginning January 1, 2024 through December 31, 2024, and (ii) subject to the Reporting Person remaining in continuous service through the vesting date.
- [F2]These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001529196
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:53 PM ET
- Size
- 5.9 KB